5th International Advanced Research Workshop on In Silico Oncology and Cancer Investigation

22 - 23 October 2012, Athens, Greece.
Cancer is a natural phenomenon and as such it should be amenable to mathematical and computational description. Clinically driven complex multiscale cancer models can produce rather realistic spatio-temporal simulations of concrete clinical interventions such as radio-chemotherapy applied to individual patients.

Clinical data processing procedures and computer technologies play an important role in this context. Following clinical adaptation and validation within the framework of clinico-genomic trials, models are expected to enhance individualized treatment optimization. The latter constitutes the long term goal of the emergent scientific, technological and medical discipline of in silico oncology.

Treatment optimization is to be achieved through experimentation in silico i.e. on the computer. Moreover, provision of insight into tumour dynamics and optimization of clinical trial design and interpretation constitute short- and mid-term goals of this new domain. Researchers working either in the area of in silico oncology or in the broader cancer research domain yet with an interest in computational oncology are invited to submit short papers.

The workshop is meant to be an excellent opportunity for both shaping and advancing the discipline.

Organizing Committee

  • G. Stamatakos, PhD, ICCS - National Technical University of Athens (GR), General Chair
  • Ν. Graf, MD, University Clinic of Saarland (DE)
  • K. Marias, PhD, Foundation for Research and Technology, Hellas (GR)
  • M. Akay, PhD, University of Houston (USA)
  • R.Radhakrishnan, PhD, University of Pennsylvania (USA)
  • D. Dionysiou, PhD, ICCS - National Technical University of Athens (GR)
  • V. Sakkalis, PhD, Foundation for Research and Technology - Hellas (GR)
  • N. Uzunoglu, PhD, ICCS - National Technical University of Athens (GR)

Important Dates
Paper submissions due: September 1, 2012.
Notification of acceptance: September 21, 2012. Camera ready papers due: September 30, 2012.

This year the 5th International Αdvanced Research Workshop on In Silico Oncology and Cancer Investigation will also be the TUMOR project workshop.

The TUMOR project aims at developing a European clinically oriented semantic-layered cancer digital model repository from existing EU projects that will be interoperable with the US grid enabled semantic-layered digital model repository platform at CViT.org (Center for the Development of a Virtual Tumor, Massachusetts General Hospital (MGH), Boston, USA) which is NIH/NCI-caGRID compatible.

For further information, please visit:
http://www.5th-iarwisoci.iccs.ntua.gr

Most Popular Now

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

Forging a Novel Therapeutic Path for Pat…

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are born with it and much fewer boys. It is caused by...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

Integrating Care Records is Good. Using …

Opinion Article by Dr Paul Deffley, Chief Medical Officer, Alcidion. A single patient record already exists in the NHS. Or at least, that’s a perception shared by many. A survey of...